<mxfile host="Electron" modified="2023-05-24T16:25:04.177Z" agent="Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) draw.io/21.2.8 Chrome/112.0.5615.165 Electron/24.2.0 Safari/537.36" etag="hBraXDU6wb0WyZ-GDI1Q" version="21.2.8" type="device" pages="3">
  <diagram id="H1RUSUYUqy5vCV2Sjo-0" name="Antenatal">
    <mxGraphModel dx="854" dy="854" grid="1" gridSize="5" guides="1" tooltips="1" connect="1" arrows="1" fold="1" page="1" pageScale="1" pageWidth="1169" pageHeight="827" math="0" shadow="0">
      <root>
        <mxCell id="0" />
        <mxCell id="1" parent="0" />
        <mxCell id="9rko5bfmQdZMndDFAWf5-10" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#182230;fontColor=#FFFFFF;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="40" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-11" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="70" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-12" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Stop smoking&lt;br style=&quot;font-size: 11px;&quot;&gt;• ↓ovulation, abn sperm production&lt;br&gt;• 2x miscarriage risk&lt;br&gt;• a/w preterm labour, fetal growth &lt;br&gt;&amp;nbsp; restriction, placenta praevia, &lt;br&gt;&amp;nbsp; abruption&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="90" width="190" height="85" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-13" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Wt loss: BMI &amp;gt;18.5 &amp;amp; &amp;lt;30&lt;br&gt;• Avoid contact sports please&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="345" width="190" height="30" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-14" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Supplementation: &lt;u&gt;folic acid&lt;/u&gt;&lt;br&gt;• Essential for DNA and RNA&lt;br&gt;• Causes of deficiency&lt;br&gt;&amp;nbsp; - Phenytoin&amp;nbsp;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;- MTX&lt;br&gt;&amp;nbsp; - Pregnancy&amp;nbsp;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;- Alcohol excess&lt;br&gt;• Consequences of deficiency&lt;br&gt;&amp;nbsp; - Megaloblastic anaemia&lt;br&gt;&amp;nbsp; - Neural tube defects&lt;br&gt;• Folic acid &lt;b&gt;0.4 mg daily &amp;gt;1mo &lt;br&gt;&amp;nbsp; preconception until ≥13w&lt;/b&gt;&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ 5 mg/d if past neural tube &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;/span&gt;defects, on antiepileptics, &lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;diabetic, obese, HIV+ve on co-&lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;trimoxazole prophylaxis, or &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;sickle cell disease.&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="375" width="190" height="205" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-15" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Supplementation: &lt;u&gt;Vitamin D&lt;/u&gt;&lt;br&gt;• 10 mcg/d for all women, esp in pts &lt;br&gt;&amp;nbsp; with darker skin or those who have &lt;br&gt;&amp;nbsp; covered skin&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="625" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-16" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Alcohol abstinence advised&lt;br&gt;• High levels cause fetal alcohol &lt;br&gt;&amp;nbsp; syndrome. ↑risk of miscarriage&amp;nbsp;&lt;br&gt;• Minimal drinking (1-2u/w) has not &lt;br&gt;&amp;nbsp; been shown to adversely affect &lt;br&gt;&amp;nbsp; fetus, but crosses placenta and can &lt;br&gt;&amp;nbsp; affect fetal brain&lt;br&gt;• NICE rec &amp;lt;1u/24h; binge drinking &lt;br&gt;&amp;nbsp; (&amp;gt;5u/session esp harmful)&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="175" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-17" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Recreational drugs a/w miscarriage, &lt;br&gt;&amp;nbsp; preterm birth, poor fetal &lt;br&gt;&amp;nbsp; development, intrauterine death&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="60" y="300" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-18" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Pre-existing medical disorders&lt;br&gt;• Poorly controlled – same or worse&lt;br&gt;• Well controlled – same or better&lt;br&gt;• Refer for specialist help asap&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="260" y="70" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-19" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Medication: ∆ prior to conception to ↓risk of teratogenesis: antiepileptics, ACEI, immune-modulators&lt;br&gt;• Avoid OTCs as much as possible&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="260" y="130" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="9rko5bfmQdZMndDFAWf5-20" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Spontaneous miscarriage: 15-20% of all pregnancies, ↑ if extremes of age. Recurrent miscarriage = &amp;gt;3 consecutive miscarriages&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" parent="1" vertex="1">
          <mxGeometry x="260" y="435" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-1" value="Physiological changes in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#345e6a;fontColor=#FFFFFF;strokeColor=#345E6A;" parent="1" vertex="1">
          <mxGeometry x="480" y="40" width="135" height="35" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-2" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;&lt;u style=&quot;font-size: 10px;&quot;&gt;Hormonal changes&lt;/u&gt;&lt;br style=&quot;font-size: 10px;&quot;&gt;• Progesterone:&amp;nbsp;↓muscle excitability, &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; ↑body temp&lt;br style=&quot;font-size: 10px;&quot;&gt;• Estrogens (90% estriol)&amp;nbsp;↑breast&amp;nbsp;and &lt;br&gt;&amp;nbsp; nipple growth, water retention,&amp;nbsp;protein &lt;br&gt;&amp;nbsp; synthesis&lt;br style=&quot;font-size: 10px;&quot;&gt;• Thyroid:&amp;nbsp;↑ in size&lt;br style=&quot;font-size: 10px;&quot;&gt;• Prolactin:&amp;nbsp;↑ throughout pregnancy&lt;br style=&quot;font-size: 10px;&quot;&gt;• Cortisol:&amp;nbsp;↑ output, but unbound levels &lt;br&gt;&amp;nbsp; constant&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#345E6A;" parent="1" vertex="1">
          <mxGeometry x="480" y="85" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-3" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;&lt;u style=&quot;font-size: 10px;&quot;&gt;Genital changes&lt;/u&gt;&lt;br style=&quot;font-size: 10px;&quot;&gt;• Uterus: 100g&amp;nbsp;→ 1.1kg :0&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ hypertrophy occurs&amp;nbsp;≤20w, then &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;stretching&lt;br style=&quot;font-size: 10px;&quot;&gt;• Vaginal discharge&amp;nbsp;↑ due to cervical &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; ectopy, cell desquamation,&amp;nbsp;↑mucus &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; production from vasocongested vagina&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#345E6A;" parent="1" vertex="1">
          <mxGeometry x="480" y="210" width="190" height="90" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-4" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;&lt;u style=&quot;font-size: 10px;&quot;&gt;Haemodynamic changes&lt;/u&gt;&lt;br style=&quot;font-size: 10px;&quot;&gt;• Blood: plasma volume rises from 8&amp;nbsp;to &lt;br&gt;&amp;nbsp; 32w (50% &amp;gt;non-pregnant)&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ RBC&amp;nbsp;↑30% if supplements taken&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;gt; Hb falls due to dilution&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ WCC, platelets, ESR, cholesterol, &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;β-globulin, fibrinogen&amp;nbsp;↑&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ Albumin and GGT&amp;nbsp;↓&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ Urea and creatinine&amp;nbsp;↓&lt;br style=&quot;font-size: 10px;&quot;&gt;• Cardiovascular&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - CO↑ - SV&amp;nbsp;↑10%, HR ↑~15b/min&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - Peripheral resistance&amp;nbsp;↓&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - BP (esp DBP)&amp;nbsp;↓ during 2nd trim, then &lt;br&gt;&amp;nbsp; &amp;nbsp; rises to non-pregnant levels&amp;nbsp;by term&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - Varicose veins may form&lt;br style=&quot;font-size: 10px;&quot;&gt;• IVC compression from 20w will&amp;nbsp;↓CO by &lt;br&gt;&amp;nbsp; 30-40% (supine&amp;nbsp;hypotension)&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ left lateral position or tilt ~15&#39; to&amp;nbsp;the &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;left to relieve this&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#345E6A;" parent="1" vertex="1">
          <mxGeometry x="480" y="300" width="190" height="235" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-6" value="&lt;font style=&quot;&quot;&gt;&lt;u style=&quot;font-size: 10px;&quot;&gt;Others&lt;/u&gt;&lt;br style=&quot;font-size: 10px;&quot;&gt;• Ventilation&amp;nbsp;↑40% 2/2 progesterone&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp;&amp;nbsp;↳ O2&amp;nbsp;↑20% only&amp;nbsp; ↳ SOB common&lt;br style=&quot;font-size: 10px;&quot;&gt;• Gut motility&amp;nbsp;↓ - constipation,&amp;nbsp;delayed &lt;br&gt;&amp;nbsp; gastric emptying, lax esophageal &lt;br&gt;&amp;nbsp; sphincter, heartburn&lt;br style=&quot;font-size: 10px;&quot;&gt;• Renal size&amp;nbsp;↑1cm in length,&amp;nbsp;GFR&amp;nbsp;↑60% &lt;br&gt;&amp;nbsp; and ↑pressure on&amp;nbsp;bladder → &lt;br&gt;&amp;nbsp; ↑micturation&lt;br style=&quot;font-size: 10px;&quot;&gt;• Skin pigmentation: linea nigra, nipples, &lt;br&gt;&amp;nbsp; chloasma, palmar erythema, spider &lt;br&gt;&amp;nbsp; naevi, striae&lt;br style=&quot;font-size: 10px;&quot;&gt;• Hair shedding in periperium&lt;br&gt;• Pregnancy tests: may be +ve from 9d &lt;br&gt;&amp;nbsp; post-conception (or from day 23 of a 28 &lt;br&gt;&amp;nbsp; day cycle). False +ve rate is low.&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#345E6A;" parent="1" vertex="1">
          <mxGeometry x="480" y="535" width="190" height="200" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-7" value="Antenatal care" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#a63a52;fontColor=#FFFFFF;strokeColor=#A63A52;" parent="1" vertex="1">
          <mxGeometry x="700" y="40" width="95" height="20" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-8" value="&lt;font style=&quot;&quot;&gt;&lt;u&gt;1st antenatal (booking) visit&lt;/u&gt;&lt;br&gt;&lt;b&gt;Full Hx taking&lt;/b&gt;&lt;br&gt;• FHx of DM, HTN, fetal abnormality, &lt;br&gt;&amp;nbsp; inheritable disease, twins?&lt;br&gt;• Concurrent illness, FGM (&quot;cut&quot;?), &lt;br&gt;&amp;nbsp; ↑risk for VTE (±LMWH)&lt;br&gt;• Is GDM a risk? 75g OGTT at 28w if &lt;br&gt;&amp;nbsp; BMI &amp;gt;30, previous macrosomia, &lt;br&gt;&amp;nbsp; 1st-degree family DM, ethnic risk&lt;br&gt;&amp;nbsp;&amp;nbsp;↳ if previous GDM, screen at 16w &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;and again at 28w&lt;br&gt;• Past mental illness? If serious &lt;br&gt;&amp;nbsp; (SCZ, bipolar, self-harm) or past &lt;br&gt;&amp;nbsp; postnatal depression: antenatal Ax &lt;br&gt;&amp;nbsp; by perinatal mental health team&lt;br&gt;• Women born outside UK:&amp;nbsp;↑Hb &lt;br&gt;&amp;nbsp; problems, BBV, pre-existing cardiac &lt;br&gt;&amp;nbsp; disease&lt;br&gt;• Unsupported women: ask about &lt;br&gt;&amp;nbsp; domestic violence, check for &lt;br&gt;&amp;nbsp; substance abuse&lt;br&gt;&lt;b&gt;Examination&lt;/b&gt;: heart, lungs, BP, wt &amp;amp; BMI, abdomen. ? varicose veins&lt;br&gt;•&amp;nbsp;± pap smear&amp;nbsp;&lt;span style=&quot;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/span&gt;&lt;span style=&quot;&quot;&gt;&lt;/span&gt;• FGM&lt;br&gt;&lt;b&gt;Test&lt;/b&gt;: Hb, blood group, infectious disease, screen for sickle cell and thalassemia&lt;br&gt;• Offer screening for chromosomal &lt;br&gt;&amp;nbsp; and structural abn&amp;nbsp;&lt;br&gt;• 12w scan also confirms EDD&lt;br&gt;Advise on: (see counselling) + use of seat belts (above/below bump, not over it), offer antenatal classes, info on maternity benefits.&lt;br&gt;• Travel OK up to 36w but check with &lt;br&gt;&amp;nbsp; airline; avoid malarial areas&lt;br&gt;&amp;nbsp;&amp;nbsp;↳ may require fit to fly letter &amp;gt;32w&lt;br&gt;• Intercourse ok if no bleeding&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#A63A52;" parent="1" vertex="1">
          <mxGeometry x="700" y="70" width="190" height="505" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-9" value="&lt;font style=&quot;&quot;&gt;&lt;u&gt;Later visits&lt;br&gt;&lt;/u&gt;• Discuss screening results, tx &lt;br&gt;&amp;nbsp; anaemia and UTI&lt;br&gt;• At each visit, check for protein, BP, &lt;br&gt;&amp;nbsp; fundal height&lt;br&gt;• Visits are at &amp;lt;12, 16, 25, 28, 31, 34, &lt;br&gt;&amp;nbsp; 36, 38, 40, 41 (premip)&lt;br&gt;• 28w: Hb, Rh abs - give anti-D prn&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#A63A52;" parent="1" vertex="1">
          <mxGeometry x="700" y="575" width="190" height="110" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-10" value="Use of anti-D" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ea6c81;fontColor=#FFFFFF;strokeColor=#EA6C81;" parent="1" vertex="1">
          <mxGeometry x="500" y="870" width="85" height="20" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-11" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;Dose - 250u for gestation &amp;lt;20w&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;span style=&quot;font-size: 10px; background-color: initial;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;- 500u if &amp;gt;20w&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/span&gt;• Give in deltoid IM&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - IV or SC if bleeding disorder&lt;br style=&quot;font-size: 10px;&quot;&gt;• From 20w, do Kleihauer test (FBC &lt;br&gt;&amp;nbsp; bottle of maternal blood, so can be&amp;nbsp; &lt;br&gt;&amp;nbsp; counted to measure the bleed&#39;s &lt;br&gt;&amp;nbsp; volume) - do not give anti-D if&amp;nbsp;already &lt;br&gt;&amp;nbsp; sensitised&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#EA6C81;" parent="1" vertex="1">
          <mxGeometry x="500" y="900" width="190" height="115" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-13" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;Postnatal use: 500u normal dose&lt;br style=&quot;font-size: 10px;&quot;&gt;• Anti-D: for all Rh-ve women where &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; baby&#39;s group cannot be&amp;nbsp;determined, or &lt;br&gt;&amp;nbsp; if baby&#39;s group is&amp;nbsp;unknown 72h post-&lt;br&gt;&amp;nbsp; delivery&lt;br style=&quot;font-size: 10px;&quot;&gt;• Do a Kleihauer test on all eligible for &lt;br&gt;&amp;nbsp; anti-D&lt;br style=&quot;font-size: 10px;&quot;&gt;• Any mother receiving anti-D&amp;nbsp;prenatally &lt;br&gt;&amp;nbsp; should also receive it&amp;nbsp;postnatally &lt;br&gt;&amp;nbsp; unless she delivers an&amp;nbsp;Rh-ve baby&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#EA6C81;" parent="1" vertex="1">
          <mxGeometry x="500" y="1015" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-14" value="&lt;font style=&quot;font-size: 10px;&quot;&gt;Anti-D in miscarriage in Rh-ve mums&lt;br style=&quot;font-size: 10px;&quot;&gt;• Give to all having surgical or &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; medical terminations of pregnancy, &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; evacuation of hydatidiform mole,&amp;nbsp;and &lt;br&gt;&amp;nbsp; ectopic pregnancies, unless&amp;nbsp;they are &lt;br&gt;&amp;nbsp; known to have anti-D abs&lt;br style=&quot;font-size: 10px;&quot;&gt;• Give where spontaneous&amp;nbsp;miscarriage &lt;br&gt;&amp;nbsp; requires termination&lt;br style=&quot;font-size: 10px;&quot;&gt;• Anti-D should be given where &lt;br&gt;&amp;nbsp; spontaneous complete miscarriage &lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; occurs after 12w&lt;br style=&quot;font-size: 10px;&quot;&gt;• Threatened miscarriage&amp;nbsp;≥12w; if &lt;br&gt;&amp;nbsp; bleeding continues intermittently, give it &lt;br&gt;&amp;nbsp; q6w until delivery&lt;br style=&quot;font-size: 10px;&quot;&gt;• Routine anti-D not rec with threatened &lt;br&gt;&amp;nbsp; miscarriages before 12w&amp;nbsp;&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#EA6C81;" parent="1" vertex="1">
          <mxGeometry x="500" y="1140" width="190" height="200" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-15" value="&lt;font style=&quot;&quot;&gt;Anti-D in pregnancy in Rh-ve mums&lt;br style=&quot;font-size: 10px;&quot;&gt;• Take blood sample before 28w to look &lt;br&gt;&amp;nbsp; for antibodies&lt;br&gt;• Give anti-D 500u at 28 and 34w to Rh-&lt;br&gt;&amp;nbsp; ve women&lt;br&gt;• When significant transplacental &lt;br&gt;&amp;nbsp; haemorrhage may occur, use 250u &lt;br&gt;&amp;nbsp; before 20w gestation, 500u after 20w&lt;br style=&quot;font-size: 10px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=10;strokeColor=#EA6C81;" parent="1" vertex="1">
          <mxGeometry x="500" y="1340" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-17" value="&lt;font style=&quot;&quot;&gt;• Most occur in low-risk patients with &lt;br&gt;&amp;nbsp; uncomplicated pregnancies&lt;br style=&quot;font-size: 11px;&quot;&gt;• Women at higher risk: previously &lt;br&gt;&amp;nbsp; affected child, pre-existing DM, &lt;br&gt;&amp;nbsp; epilepsy&lt;br&gt;• Everyone in UK to be offered tests&lt;br&gt;•&amp;nbsp;❗️ tests are not diagnostic, and can &lt;br&gt;&amp;nbsp; be declined by the woman&amp;nbsp;❗️&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="70" width="190" height="110" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-18" value="&lt;font style=&quot;&quot;&gt;US can detect pregnancy from approx 5w of gestation&lt;br&gt;• Used to date a pregnancy&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="180" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-19" value="&lt;font style=&quot;&quot;&gt;&lt;u&gt;Nuchal translucency (NT)&lt;/u&gt; at 11-13w&amp;nbsp;&lt;br&gt;• Determines viability, dates &lt;br&gt;&amp;nbsp; pregnancy, Dx multiple pregnancy &lt;br&gt;&amp;nbsp; and chorionicity&lt;br&gt;• Screening for chromosomal abn by &lt;br&gt;&amp;nbsp; nuchal fold measurement + bloods&lt;br&gt;•&amp;nbsp;↑ fetal NT may reflect fetal heart &lt;br&gt;&amp;nbsp; failure, serious abn of heart and &lt;br&gt;&amp;nbsp; great arteries&lt;br&gt;• Bloods + NT - if risk &amp;lt;1:150, &lt;br&gt;&amp;nbsp; invasive testing is offered&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="225" width="190" height="150" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-20" value="&lt;font style=&quot;&quot;&gt;&lt;u&gt;Anomaly scan&lt;/u&gt;&lt;br&gt;• Detailed US at 18-22w to detect &lt;br&gt;&amp;nbsp; structural malformations&lt;br&gt;• About 30min to complete, &lt;br&gt;&amp;nbsp; sensitivity varies depending on &lt;br&gt;&amp;nbsp; many factors&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="375" width="190" height="85" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-21" value="&lt;font style=&quot;&quot;&gt;&lt;b&gt;&lt;u&gt;Lethal anomalies&lt;/u&gt;&lt;/b&gt;&lt;br&gt;• Anencephaly&lt;br&gt;• Bilateral renal agenesis&lt;br&gt;• Some major cardiac abn&lt;br&gt;• Trisomies 13 and 18&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="460" width="190" height="70" as="geometry" />
        </mxCell>
        <mxCell id="WNwKVluJ0oFB0plMWCBK-22" value="&lt;font style=&quot;&quot;&gt;Fetal echo: offered to those at high risk of fetal cardiac abn - FHx or personal Hx, NT &amp;gt;3.5mm, drugs in pregnancy (lithium), DM, mono-chorionic twins&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="530" width="190" height="70" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-1" value="&lt;font style=&quot;&quot;&gt;Other types of scans&lt;br&gt;• Soft markers – slightly more &lt;br&gt;&amp;nbsp; common in chromosomally abn &lt;br&gt;&amp;nbsp; fetuses&lt;br&gt;• Fetal growth scans&lt;br&gt;• Doppler US – blood flow; useful in &lt;br&gt;&amp;nbsp; high-risk pregnancies&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="600" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-5" value="Structural abnormalities" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#f39597;fontColor=#000000;strokeColor=#F39597;" parent="1" vertex="1">
          <mxGeometry x="920" y="40" width="150" height="20" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-6" value="Aneuploidy &amp;amp; screening" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#e2782c;fontColor=#000000;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="870" width="150" height="20" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-7" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Trisomy 21 (Down)&lt;br&gt;• 10% die before 5yo, life expectancy &lt;br&gt;&amp;nbsp; is 55yo. ↑rate of spontaneous &lt;br&gt;&amp;nbsp; miscarriage&lt;br&gt;• ↑maternal age → ↑risk&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; &amp;lt;25yo 1:1500 vs 45yo 1:30&lt;br&gt;• Congenital cardiac malformations &lt;br&gt;&amp;nbsp; common, esp VSD or ASD, also &lt;br&gt;&amp;nbsp; duodenal atresia&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="900" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-8" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Trisomy 18 (Edwards)&lt;br&gt;• Most die soon after birth; &amp;gt;1yo rare&lt;br&gt;• Small chin, low set ears, rocker &lt;br&gt;&amp;nbsp; bottom feet, VSD&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="1025" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-9" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Trisomy 13 (Patau)&lt;br&gt;• Most die soon after birth&lt;br&gt;• Microcephaly, holoprosencephaly, &lt;br&gt;&amp;nbsp; exomphalos, cleft lip/palate&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="1085" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-10" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Screening with &lt;b&gt;&lt;u&gt;combined test&lt;/u&gt;&lt;/b&gt;&lt;br&gt;• Uses NT + free hCG + pregnancy-&lt;br&gt;&amp;nbsp; associated plasma protein (PAPP-&lt;br&gt;&amp;nbsp; A) + woman&#39;s age&lt;br&gt;• w11 to 13+6&lt;br&gt;• Detects 90% of all aneuploidies&lt;br&gt;• Tests will return either a &#39;lower&#39; or &lt;br&gt;&amp;nbsp; &#39;higher chance&#39; – higher chance &lt;br&gt;&amp;nbsp; (&amp;gt;1:150) → counselling&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="1145" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-11" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Screening with &lt;b&gt;&lt;u&gt;quadruple test&lt;/u&gt;&lt;/b&gt;&lt;br&gt;• If women book later in pregnancy &lt;br&gt;&amp;nbsp; (w15-20)&lt;br&gt;• AFP, unconjugated estriol, hCG, &lt;br&gt;&amp;nbsp; inhibin A&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="1270" width="190" height="70" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-12" value="&lt;span style=&quot;white-space: pre;&quot;&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;AFP&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;U&lt;/span&gt;cO&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;hCG&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;inhA&lt;br&gt;Down&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;↑&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;span style=&quot;white-space: pre;&quot;&gt; &lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;↓&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;↑&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;↑&lt;br&gt;Edwards/&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;/span&gt;↓&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;↓&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;↓&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;~&lt;/span&gt;&lt;br&gt;&amp;nbsp; Patau&lt;br&gt;Neural tube&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;↑&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;~&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;~&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;&lt;span style=&quot;white-space: pre;&quot;&gt;	&lt;/span&gt;~&lt;/span&gt;&amp;nbsp;&lt;br&gt;&amp;nbsp; defects" style="text;html=1;strokeColor=none;fillColor=none;align=left;verticalAlign=top;whiteSpace=wrap;rounded=0;fontSize=9;fontColor=#000000;spacing=0;spacingTop=-5;" parent="1" vertex="1">
          <mxGeometry x="60" y="1345" width="200" height="65" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-13" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Non-invasive prenatal screening (NIPT)&lt;br&gt;• Analyses small DNA fragments that &lt;br&gt;&amp;nbsp; circulate in the blood of a pregnant &lt;br&gt;&amp;nbsp; woman&lt;br&gt;• &amp;gt;99% sens+spec for chromosomal &lt;br&gt;&amp;nbsp; abn esp Down&lt;br&gt;• Private companies offer NIPT from &lt;br&gt;&amp;nbsp; 10w gestation&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#E2782C;" parent="1" vertex="1">
          <mxGeometry x="60" y="1415" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-14" value="Invasive testing" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#f7a54d;fontColor=#000000;strokeColor=#F7A54D;" parent="1" vertex="1">
          <mxGeometry x="280" y="870" width="100" height="20" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-15" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Chorionic villus biopsy&lt;br&gt;• 10-13w; allows earlier termination &lt;br&gt;&amp;nbsp; than amniocentesis&lt;br&gt;• Placenta sampled via transabd or &lt;br&gt;&amp;nbsp; trans-cervical approach&lt;br&gt;• Risks: ↑miscarriage by 1-2%, &lt;br&gt;&amp;nbsp; ↑transmission of BBV, &lt;br&gt;&amp;nbsp; contamination by maternal cells, &lt;br&gt;&amp;nbsp; false +ve or -ve&lt;br&gt;• Not recommended for dichorionic&lt;br&gt;&amp;nbsp; multiple pregnancy&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F7A54D;" parent="1" vertex="1">
          <mxGeometry x="280" y="900" width="190" height="150" as="geometry" />
        </mxCell>
        <mxCell id="fITFJkFbMG79iavzdVpm-16" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Amniocentesis&lt;br&gt;• 16w onwards&lt;br&gt;• Aspiration of fluid containing fetal &lt;br&gt;&amp;nbsp; cells shed from skin and gut via &lt;br&gt;&amp;nbsp; small needle passed transabd&lt;br&gt;• Fetal loss rate is ~1% at 16w&lt;br&gt;• Anti-D needed in all Rh-ve F&lt;br&gt;• Can Dx fetal infections such as &lt;br&gt;&amp;nbsp; CMV, ↓excess miscarriage rate&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#F7A54D;" parent="1" vertex="1">
          <mxGeometry x="280" y="1050" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="5IpXdjx-9vjoLSlwrZrc-1" value="OBGYN: updated 2023" style="text;html=1;strokeColor=none;fillColor=none;align=right;verticalAlign=top;whiteSpace=wrap;rounded=0;fontSize=9;fontColor=#000000;spacing=0;spacingTop=-5;" parent="1" vertex="1">
          <mxGeometry x="1000" y="785" width="120" height="10" as="geometry" />
        </mxCell>
        <mxCell id="d2C18sYbVOM_otTZrBkc-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Work&lt;br&gt;• Maternity rights and benefits&lt;br&gt;• Usually safe to continue working &lt;br&gt;&amp;nbsp; unless occupational hazards&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="260" y="275" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="d2C18sYbVOM_otTZrBkc-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Air travel&lt;br&gt;• Avoid after 37w for all singletons&lt;br&gt;• Avoid after 32w for multiples&lt;br&gt;• For complicated pregnancies, &lt;br&gt;&amp;nbsp; review risk factors and advice&lt;br&gt;• A/w ↑risk of VTE&lt;br&gt;&amp;nbsp; - Wear compression stockings!&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="260" y="335" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="d2C18sYbVOM_otTZrBkc-3" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Supplementation: &lt;u&gt;PO iron&lt;/u&gt;&lt;br&gt;• Only if anaemic – &amp;lt;105g/L in 1st &lt;br&gt;&amp;nbsp; trim or &amp;lt;115 g/L thereafter&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="60" y="580" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="39uvDKgce68YC7NuWjWF-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Supplementation: &lt;u&gt;Vitamin A&lt;/u&gt;&lt;br&gt;• high doses (&amp;gt;700 mcg) are&lt;br&gt;&amp;nbsp; teratogenic; avoid eating liver&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="60" y="685" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-1" value="Antenatal timetable" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#182230;fontColor=#FFFFFF;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="720" y="870" width="65" height="30" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;NICE recommendations&lt;br&gt;• 10 visits in 1st preg if uncomplicated&lt;br&gt;• 7 visits in subsequent if uncomp&lt;br&gt;• No need to be seen by consultant if &lt;br&gt;&amp;nbsp; uncomplicated&lt;br&gt;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="795" y="870" width="200" height="75" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-3" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;8-12w (ideally &amp;lt;10w)&lt;br&gt;• Booking visit&lt;br&gt;• Booking bloods + urine culture &lt;br&gt;&amp;nbsp; (asymptomatic bacteriuria)&lt;br&gt;&lt;br&gt;10 - 13+6w: early scan to confirm &lt;br&gt;&amp;nbsp; dates, exclude multiple pregnancies&lt;br&gt;&lt;br&gt;11 - 13+6w: Down&#39;s syndrome &lt;br&gt;&amp;nbsp; screening including nuchal scan&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="720" y="955" width="200" height="140" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-4" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;16w: information on anomaly and &lt;br&gt;&amp;nbsp; blood results.&lt;br&gt;• If Hb &amp;lt;110 g/L, consider iron&lt;br&gt;• Routine care: BP and urine dipstick&lt;br&gt;&lt;br&gt;18 - 20+6w: anomaly scan&lt;br&gt;&lt;br&gt;25w (if premip)&lt;br&gt;• Routine care: BP, urine dipstick, &lt;br&gt;&amp;nbsp; symphysis-fundal height&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="720" y="1095" width="200" height="140" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-5" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;28w • Routine care&lt;br&gt;• 2nd screen for anaemia and atypical &lt;br&gt;&amp;nbsp; red cell alloantibodies&lt;br&gt;&amp;nbsp; ↳ if Hb &amp;lt;105g/L, consider iron&lt;br&gt;• First dose of anti-D prophylaxis to &lt;br&gt;&amp;nbsp; rhesus -ve women&lt;br&gt;&lt;br&gt;31w (if premip) • Routine care&lt;br&gt;&lt;br&gt;34w • Routine care&lt;br&gt;• 2nd dose of anti-D (depending on &lt;br&gt;&amp;nbsp; local regime)&lt;br&gt;• Info on labour and birth plan&lt;br&gt;&lt;br&gt;36w • Routine care&lt;br&gt;• Check presentation: offer external &lt;br&gt;&amp;nbsp; cephalic version if indicated&lt;br&gt;• info on breastfeeding, vitamin K, &lt;br&gt;&amp;nbsp; baby-blues&lt;br&gt;&lt;br&gt;38w • Routine care&lt;br&gt;&lt;br&gt;40w (if premip) • Routine care&lt;br&gt;• Discussion about options for &lt;br&gt;&amp;nbsp; prolonged pregnancy&lt;br&gt;&lt;br&gt;41w – same as 40w visit&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="720" y="1235" width="200" height="360" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-6" value="&lt;font style=&quot;&quot;&gt;Offer screening for these:&amp;nbsp;&lt;br&gt;&lt;div style=&quot;&quot;&gt;• Anaemia&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Bacteriuria&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Blood group, Rhesus status&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&amp;nbsp; and&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;anti-&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;RBC&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;antibodies&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Down&#39;s syndrome&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Fetal anomalies&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Hepatitis B&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• HIV&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Neural tube defects&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Risk factors for pre-eclampsia&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Syphilis&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;Screening depending on Hx:&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Placenta praevia&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Psychiatric illness&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Sickle cell disease&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Tay-Sachs disease&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Thalassaemia&lt;/div&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="930" y="955" width="170" height="255" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-7" value="Do not offer screening routinely:&lt;br&gt;•&amp;nbsp;Bacterial vaginosis&lt;div&gt;• Chlamydia&lt;/div&gt;&lt;div&gt;• Cytomegalovirus&lt;/div&gt;&lt;div&gt;• Fragile X&lt;/div&gt;&lt;div&gt;• Hepatitis C&lt;/div&gt;&lt;div&gt;• Group B Streptococcus&lt;/div&gt;&lt;div&gt;• Toxoplasmosis&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="930" y="1220" width="170" height="110" as="geometry" />
        </mxCell>
        <mxCell id="LE78d4ADtx86MWKZAMgd-8" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Diet&lt;br&gt;• Avoid liver and Vit A&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;• Limit caffeine to 200 mg/d (≈2 cups&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; of tea or coffee)&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;• Cook meat thoroughly&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;• Avoid cheese, shellfish &amp;amp; raw fish&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#000000;" vertex="1" parent="1">
          <mxGeometry x="260" y="190" width="190" height="85" as="geometry" />
        </mxCell>
      </root>
    </mxGraphModel>
  </diagram>
  <diagram id="fzbKCfBaEdE-LhRpT_Ib" name="Preg conditions">
    <mxGraphModel dx="512" dy="712" grid="1" gridSize="5" guides="1" tooltips="1" connect="1" arrows="1" fold="1" page="1" pageScale="1" pageWidth="1169" pageHeight="827" math="0" shadow="0">
      <root>
        <mxCell id="0" />
        <mxCell id="1" parent="0" />
        <mxCell id="B3leuZshiXndTRsJvY1I-1" value="Minor symptoms" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#540d6e;fontColor=#FFFFFF;strokeColor=#540D6E;" parent="1" vertex="1">
          <mxGeometry x="40" y="40" width="105" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;• HA, palpitations, fainting&lt;br&gt;&amp;nbsp; - 2/2 dilated peripheral circulation, &lt;br&gt;&amp;nbsp; &amp;nbsp; ↑sweating and feeling hot&amp;nbsp;&lt;br&gt;&amp;nbsp; - Mx: ↑fluid intake, stand slowly&lt;br&gt;• Urinary frequency&lt;br&gt;&amp;nbsp; - 2/2 pressure of fetal head on &lt;br&gt;&amp;nbsp; &amp;nbsp; bladder in later pregnancy, ↑GFR&lt;br&gt;&amp;nbsp; - exclude UTI&lt;br&gt;• Abdominal pain&lt;br&gt;• Breathlessness – r/o VTE&lt;br&gt;• Constipation&lt;br&gt;&amp;nbsp; - 2/2 ↓gut motility&lt;br&gt;&amp;nbsp; - Mx: ↑fluids, high fibre diet&lt;br&gt;&amp;nbsp; - Avoid stimulant laxatives&lt;br&gt;• GORD&lt;br&gt;&amp;nbsp; - 2/2 progesterone-mediated pyloric &lt;br&gt;&amp;nbsp; &amp;nbsp; sphincter relaxation + fetal &lt;br&gt;&amp;nbsp; &amp;nbsp; pressure&lt;br&gt;&amp;nbsp; - Mx: avoid triggers; eat small &lt;br&gt;&amp;nbsp; &amp;nbsp; meals; antacids, H2RA or PPI; use &lt;br&gt;&amp;nbsp; &amp;nbsp; more pillows and prop up&lt;br&gt;• Symphysis pubis dysfunction&lt;br&gt;&amp;nbsp; ≈ pelvic girdle pain&lt;br&gt;&amp;nbsp; - 2/2 pelvic ligament and muscle &lt;br&gt;&amp;nbsp; &amp;nbsp; relaxation&lt;br&gt;&amp;nbsp; - Mx: analgesia, physio&lt;br&gt;• Carpal tunnel syndrome&lt;br&gt;&amp;nbsp; - 2/2 fluid retention&lt;br&gt;&amp;nbsp; - Mx: wrist splints&lt;br&gt;• Itch / itchy rashes (up to 25%)&lt;br&gt;&amp;nbsp; - 2/2 common causes or pruritic &lt;br&gt;&amp;nbsp; &amp;nbsp; eruption of pregnancy&lt;br&gt;&amp;nbsp; &amp;nbsp; ↳ PEP - intensely itchy papular/ &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&amp;nbsp;plaque rash on abd + limbs; &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&amp;nbsp;common in primip &amp;gt;35w&lt;br&gt;&amp;nbsp; - Mx: emollients, weak topical &lt;br&gt;&amp;nbsp; &amp;nbsp; steroids; delivery is the cure&lt;br&gt;&amp;nbsp; - If vesicles present, think of &lt;br&gt;&amp;nbsp; &amp;nbsp; pemphigoid gestationis – can &lt;br&gt;&amp;nbsp; &amp;nbsp; cause fatal heat loss and cardiac &lt;br&gt;&amp;nbsp; &amp;nbsp; failure. Refer early. May recur.&lt;br&gt;• Ankle oedema&lt;br&gt;&amp;nbsp; - Measure BP, check urine for &lt;br&gt;&amp;nbsp; &amp;nbsp; protein, check legs for FVT&lt;br&gt;&amp;nbsp; - Mx: rest, leg elevation&lt;br&gt;&amp;nbsp; - Reassure that harmless unless in &lt;br&gt;&amp;nbsp; &amp;nbsp; pre-eclampsia&lt;br&gt;• Leg cramps (33%)&lt;br&gt;&amp;nbsp; - Mx: ↑fluids, bananas, tonic water&lt;br&gt;&amp;nbsp; - Can be difficult to treat&lt;br&gt;• Chloasma: patch of darker &lt;br&gt;&amp;nbsp; pigmentation&lt;br&gt;• Nausea: 80%, vomitting 50% – can &lt;br&gt;&amp;nbsp; start at 4w, ↓over following weeks&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#540D6E;" parent="1" vertex="1">
          <mxGeometry x="40" y="70" width="190" height="720" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-3" value="Drugs used in psychiatry and epilepsy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ffd23f;fontColor=#000000;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="40" width="150" height="35" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-4" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;• Risk vs benefit&lt;br&gt;• Consult with specialists esp in &lt;br&gt;&amp;nbsp; severe depression, bipolar, SCZ&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ high risk of rapid postpartum &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;relapse a/w significant risks to &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;mother and infant, esp in &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;bipolar disorder (up to 50%)&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="84.5" width="190" height="100.5" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-5" value="Hyperemesis gravidarum" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ee4266;fontColor=#FFFFFF;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="40" width="155" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-6" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;D: persistant N/V in pregnancy causing wt loss &amp;gt;5%, dehydration and electrolyte imbalance&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="70" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-7" value="Pre-existing conditions in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#3bceac;fontColor=#000000;strokeColor=#3bceac;" parent="1" vertex="1">
          <mxGeometry x="900" y="40" width="145" height="35" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-8" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;&lt;u&gt;Anaemia&lt;/u&gt; of pregnancy = Hb &amp;lt; 105 g/L&lt;br&gt;• Antenatal screening at booking + 28w&lt;br&gt;• Offer PO ferrous sulfate 200 mg bd PO &lt;br&gt;&amp;nbsp; with orange juice. If unable to tolerate, &lt;br&gt;&amp;nbsp; eod or 2x/w. Avoid with tea, Ca, metal-&lt;br&gt;&amp;nbsp; containing supplements&lt;br&gt;• Thalassemia: refer to specialists&lt;br&gt;• Sickle cell: aim at Dx at birth (cord blood) &lt;br&gt;&amp;nbsp; for penicillin pneumococcal prophylaxis&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#3bceac;" parent="1" vertex="1">
          <mxGeometry x="900" y="84.5" width="220" height="125.5" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-9" value="Diabetes in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#9b5de5;fontColor=#FFFFFF;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="870" width="140" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-10" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;DM in 5% of pregnancies: &lt;br&gt;&amp;nbsp; 87.5% GDM, 7.5% T1, 5% T2&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="900" width="190" height="35" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-11" value="Anaemia in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#0ead69;fontColor=#FFFFFF;strokeColor=#0ead69;" parent="1" vertex="1">
          <mxGeometry x="900" y="460" width="140" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-12" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;• Screen at booking (8-10w) + 28w&amp;nbsp;&lt;br&gt;• Cut offs for tx with PO Fe:&amp;nbsp;&lt;br&gt;&amp;nbsp; - 1st trim: &amp;lt;110 g/L&lt;br&gt;&amp;nbsp; - 2nd/3rd: &amp;lt;105 g/L&lt;br&gt;&amp;nbsp; - Post-partum: &amp;lt;100 g/L&lt;br&gt;• PO ferrous sulphate or fumerate&lt;br&gt;&amp;nbsp; - continue for 3mo after identified to allow &lt;br&gt;&amp;nbsp; &amp;nbsp; stores to be replenished&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#0ead69;" parent="1" vertex="1">
          <mxGeometry x="900" y="490" width="220" height="110" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-13" value="Jaundice in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#00bbf9;fontColor=#FFFFFF;strokeColor=#00bbf9;" parent="1" vertex="1">
          <mxGeometry x="260" y="1141" width="140" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-14" value="• Occurs in 1:1500 pregnancies&lt;br&gt;• Dx urgently – travel Hx, DHx, BBV" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00bbf9;" parent="1" vertex="1">
          <mxGeometry x="260" y="1171" width="190" height="34" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-15" value="Hyperthyroidism in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#f15bb5;fontColor=#FFFFFF;strokeColor=#f15bb5;" parent="1" vertex="1">
          <mxGeometry x="260" y="870" width="185" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-16" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;• Usually Graves&#39; disease, can be &lt;br&gt;&amp;nbsp; a/w infertility, prematurity, fetal loss, &lt;br&gt;&amp;nbsp; malformations.&amp;nbsp;&lt;br&gt;• Mx with PTU (↓crossing placenta)&lt;br&gt;• Partial thyroidectomy if severe&lt;br&gt;• Monitor ≥monthly&amp;nbsp;&lt;br&gt;• TSH-receptor stimulating abs can &lt;br&gt;&amp;nbsp; cause fetal thyrotoxicosis (1%) &lt;br&gt;&amp;nbsp; after&amp;nbsp; 24w. Many complications.&lt;br&gt;&amp;nbsp; ↳ test TFTs in affected babies &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; frequently&lt;br&gt;&amp;nbsp; ↳ usually resolves spontaneously &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;in 2-3mo&lt;br&gt;• Thyroid storm can be ppt by labour &lt;br&gt;&amp;nbsp; – urgent tx required&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#f15bb5;" parent="1" vertex="1">
          <mxGeometry x="260" y="900" width="190" height="205" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-17" value="Malaria in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#00f5d4;fontColor=#000000;strokeColor=#00f5d4;" parent="1" vertex="1">
          <mxGeometry x="480" y="870" width="130" height="20" as="geometry" />
        </mxCell>
        <mxCell id="B3leuZshiXndTRsJvY1I-18" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;S/smx: in any woman who presents with odd behaviour, fever, jaundice, sweating, DIC, fetal distress, premature labour, seizures, or LOC → ask could this be malaria??&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;→ do thick and thin films&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;→ seek expert help&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00f5d4;" parent="1" vertex="1">
          <mxGeometry x="480" y="900" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;R: ↑hCG (multiple pregnancies, trophoblastic disease), nulliparity, obesity, FHx or PMH of HG&lt;br&gt;Smoking ↓risk of HG&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="125" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-2" value="&lt;font style=&quot;&quot;&gt;S/smx for admission / referral&lt;br&gt;&lt;div style=&quot;&quot;&gt;• Continued N/V, unable to keep&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&amp;nbsp; down liquids or oral antiemetics&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• Continued N/V, with ketonuria&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&amp;nbsp; and/or wt loss &amp;gt;5%, despite&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&amp;nbsp; treatment with oral antiemetics&lt;/div&gt;&lt;div style=&quot;&quot;&gt;• A confirmed or suspected&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&amp;nbsp; comorbidity (e.g.&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;unable to tolerate&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; oral antibiotics&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;for&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;a UTI)&lt;/span&gt;&lt;/div&gt;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="195" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-3" value="&lt;font style=&quot;&quot;&gt;Criteria for Dx&lt;br&gt;• ≥5% pre-pregnancy wt loss&lt;br&gt;• dehydration&lt;br&gt;• electrolyte imbalance&lt;br&gt;Pregnancy-Unique Quantification of Emesis (PUQE) score to classify severity of HG&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="320" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-4" value="&lt;font style=&quot;&quot;&gt;Mx:&lt;br&gt;• simple measures: rest; avoid &lt;br&gt;&amp;nbsp; triggers; bland foods; ginger; wrist &lt;br&gt;&amp;nbsp; acupuncture&lt;br&gt;☝🏻 medications&lt;br&gt;&amp;nbsp; - cyclizine or promethazine&lt;br&gt;&amp;nbsp; - prochlorperazine or &lt;br&gt;&amp;nbsp; &amp;nbsp; chlorpromazine&lt;br&gt;&amp;nbsp; - combination doxylamine/ &lt;br&gt;&amp;nbsp; &amp;nbsp; pyridoxine – not available in UK&lt;br&gt;✌🏻 medications&lt;br&gt;&amp;nbsp; - ondansetron: in first trim, a/w &lt;br&gt;&amp;nbsp; &amp;nbsp; small risk of cleft lip/palate.&lt;br&gt;&amp;nbsp; - metoclopramide or domperidone – &lt;br&gt;&amp;nbsp; &amp;nbsp; do not use &amp;gt;5d ∵ extrapyramidal &lt;br&gt;&amp;nbsp; &amp;nbsp; SE&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="540" width="190" height="220" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-7" value="&lt;font style=&quot;&quot;&gt;Complications&lt;br&gt;• AKI&amp;nbsp; &amp;nbsp; • Wernicke&#39;s encephalopathy&lt;br&gt;• Esophagitis, Mallory-Weiss tear&lt;br&gt;• VTE&lt;br&gt;• Fetal outcome: HG is a/w small &lt;br&gt;&amp;nbsp; increase in preterm birth and low &lt;br&gt;&amp;nbsp; birth weight&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="460" y="260" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-8" value="&lt;font style=&quot;&quot;&gt;Ix: • Urine dip for ketones, UTI&lt;br&gt;• FBC, U&amp;amp;Es, LFTs&lt;br&gt;• If refractory HG, check TFTs, LFTs, &lt;br&gt;&amp;nbsp; calcium, phosphate, amlyase (r/o &lt;br&gt;&amp;nbsp; pancreatitis), ABG&lt;br&gt;• US to Dx multiple pregnancy and &lt;br&gt;&amp;nbsp; r/o trophoblastic disease&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="260" y="430" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="BbwPWLgezh49i8sECwsS-9" value="&lt;font style=&quot;&quot;&gt;• Admission if refractory for tx&lt;br&gt;&amp;nbsp; - IVF&amp;nbsp; – NS+K or Hartmann&#39;s&amp;nbsp;for &lt;br&gt;&amp;nbsp; &amp;nbsp; rehydration&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; &amp;nbsp; ↳ do not give glucose as can ppt&lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&amp;nbsp;Wernicke&#39;s&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;• If vomiting still intractable, consider&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; steroids (prednisolone 40-50 mg od&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; or hydrocortisone 100 mg/12h IV)&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;• Prescribe high dose folic acid &lt;br&gt;&amp;nbsp; 5mg/d, thiamine to prevent &lt;br&gt;&amp;nbsp; Wernicke&#39;s. In hospital, give &lt;br&gt;&amp;nbsp; enoxaparin 40 mg od and anti-VTE &lt;br&gt;&amp;nbsp; stockings&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" parent="1" vertex="1">
          <mxGeometry x="460" y="70" width="190" height="180" as="geometry" />
        </mxCell>
        <mxCell id="uZyaNLeoiACAS0QK1Ym6-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Antidepressants&lt;br&gt;☝🏻 SSRIs, usually sertraline&lt;br&gt;&amp;nbsp; - small risk of persistant fetal pul &lt;br&gt;&amp;nbsp; &amp;nbsp; HTN and neonatal withdrawal&lt;br&gt;&amp;nbsp; - Avoid paroxetine&lt;br&gt;&amp;nbsp; - BF ok unless detrimental to&lt;br&gt;&amp;nbsp; &amp;nbsp; maternal well-being&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="195" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="uZyaNLeoiACAS0QK1Ym6-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Mood stabilisers (AEDs)&lt;br&gt;❌ valproate and carbamazepine &lt;br&gt;&amp;nbsp; CI in WoCA&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ valproate has 10% malformation &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;rate with NTDs, craniofacial &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;abn, 30-40% neurodevelop-&lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;mental problems&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ carbamazepine 2.2%&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ lamotrigine 2.1%&lt;br&gt;• Avoid all in BF also&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="295" width="190" height="140" as="geometry" />
        </mxCell>
        <mxCell id="uZyaNLeoiACAS0QK1Ym6-3" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Lithium a/w teratogenecity, neo-natal thyroid abn, floppy baby syndrome&lt;br&gt;• only prescribe if no other choice&lt;br&gt;• offer specialist fetal echo&lt;br&gt;• monitor drug levels q4w to 36w, &lt;br&gt;&amp;nbsp; then wkly; do not change brands&lt;br&gt;• signs of toxicity: tremor, &lt;br&gt;&amp;nbsp; drowsiness, visual disturbances&lt;br&gt;• stop Li during labour&lt;br&gt;• check 12h post-dose level, restart&amp;nbsp; &lt;br&gt;&amp;nbsp; Li based on this result&lt;br&gt;• No BF ∵ neonatal toxicity&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="435" width="190" height="165" as="geometry" />
        </mxCell>
        <mxCell id="uZyaNLeoiACAS0QK1Ym6-4" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Antipsychotics&lt;br&gt;• rates of fetal abn ↑ in SCZ even in &lt;br&gt;&amp;nbsp; those taking no drugs&lt;br&gt;• women on antipsychotics a/w wt &lt;br&gt;&amp;nbsp; gain should have OGTT&lt;br&gt;• if on clozapine, do not BF ∵ risk of &lt;br&gt;&amp;nbsp; fetal agranulocytosis&lt;br&gt;• avoid depot meds in WoCA&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="600" width="190" height="115" as="geometry" />
        </mxCell>
        <mxCell id="e2LvCCLjayVS-4CQqzNb-1" value="WoCA = women of childbearing age" style="text;html=1;strokeColor=none;fillColor=none;align=right;verticalAlign=top;whiteSpace=wrap;rounded=0;fontSize=9;fontColor=#000000;spacing=0;spacingTop=-5;" parent="1" vertex="1">
          <mxGeometry x="980" y="780" width="160" height="10" as="geometry" />
        </mxCell>
        <mxCell id="e2LvCCLjayVS-4CQqzNb-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Benzos a/w cleft lip/palate – avoid.&amp;nbsp;&lt;br&gt;• Avoid diazepam in delivery ∵ risk of &lt;br&gt;&amp;nbsp; neonatal withdrawal&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" parent="1" vertex="1">
          <mxGeometry x="680" y="715" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;&lt;u&gt;HIV&lt;/u&gt;&amp;nbsp;in pregnancy&lt;br&gt;• without intervention, 15% of babies &lt;br&gt;&amp;nbsp; acquire HIV if mother is +ve&lt;br&gt;• 2/3 vertical transmission occurs during &lt;br&gt;&amp;nbsp; pregnancy, but bfding 2x rate&lt;br&gt;• ↑risk with longer membrane rupture, viral &lt;br&gt;&amp;nbsp; load &amp;gt;400, seroconversion during preg, &lt;br&gt;&amp;nbsp; advanced disease, pre-term labour, HCV&lt;br&gt;• ≤1% risk with maternal HAART, elective &lt;br&gt;&amp;nbsp; C-sec, bottle feeding&lt;br&gt;&amp;nbsp; ↳ vaginal delivery rec if viral load &amp;lt;50 at &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;36w, otherwise C-sec&amp;nbsp;&lt;br&gt;&amp;nbsp; ↳ start zidovudine inf 4h before C-sec&lt;br&gt;• Screening at booking, 28w; if status &lt;br&gt;&amp;nbsp; unknown at labour, perform rapid test. Mx &lt;br&gt;&amp;nbsp; accordingly&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#3bceac;" parent="1" vertex="1">
          <mxGeometry x="900" y="210" width="220" height="220" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;R: BMI &amp;gt;30, previous macrosomia (≥4.5kg), previous GDM, 1st FHx, ethnicity&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="945" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-3" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Screening: OGTT&lt;br&gt;• If prev GDM, OGTT asap after &lt;br&gt;&amp;nbsp; booking, and at 24-28w.&amp;nbsp;&lt;br&gt;• If other risk factors, OGTT within &lt;br&gt;&amp;nbsp; 24-28w&lt;br&gt;• NICE rec early self-monitoring &lt;br&gt;&amp;nbsp; using blood glucose early on&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="1000" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-4" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Dx:&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&lt;b&gt;fasting glucose ≥ 5.6 mmol/L&lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;2h-OGTT ≥ 7.8 mmol/L&amp;nbsp;&lt;/b&gt;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="1100" width="190" height="30" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-5" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Mx of newly Dx GDM:&lt;br&gt;• joint DM-antenatal clinic w/in 1w&lt;br&gt;• teach self-monitoring of BGC&lt;br&gt;• advice – diet, exercise&lt;br&gt;• if fasting glucose &amp;lt;7, offer to trial&amp;nbsp; &amp;nbsp;&lt;br&gt;&amp;nbsp; diet and exercise&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ if targets not met w/in 1-2w, &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;start metformin&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ if targets not met, + insulin&lt;br&gt;• if fasting glucose ≥7 at Dx, start &lt;br&gt;&amp;nbsp; short-acting insulin&lt;br&gt;&amp;nbsp; &amp;nbsp;↳ if glucose 6-6.9 + evidence of &lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;complications, start insulin&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="1141" width="190" height="179" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-7" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Mx of previous DM&lt;br&gt;• wt loss if BMI &amp;gt;27&lt;br&gt;• stop hypoglycaemics except &lt;br&gt;&amp;nbsp; meformin, start insulin&lt;br&gt;&amp;nbsp; ↳ tight glycaemic control ↓comp&lt;br&gt;• folic acid 5 mg/d pre-conception to &lt;br&gt;&amp;nbsp; 12w gestation&lt;br&gt;• detailed&amp;nbsp;anomaly scan at 20w &lt;br&gt;&amp;nbsp; including four-chamber view of the &lt;br&gt;&amp;nbsp; heart and outflow tracts&lt;br&gt;• tx retinopathy as can worsen during &lt;br&gt;&amp;nbsp; pregnancy&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="1320" width="190" height="165" as="geometry" />
        </mxCell>
        <mxCell id="7KPMABGSPY4-bf0t2nqY-8" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;C: 50% of women with GDM develop T2DM – check fasting glucose 6w postpartum or HbA1c at 13w pp; screen annually&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" parent="1" vertex="1">
          <mxGeometry x="40" y="1495" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="V4_7HxQHBq3fb8EW7zNI-1" value="Obstetric cholestasis (0.7% prev)&lt;br&gt;• Pruritus (palms, soles) in 2nd half, &lt;br&gt;&amp;nbsp; no rash. Worse at night.&amp;nbsp;&lt;br&gt;• Dx of exclusion – r/o BBV, auto-&lt;br&gt;&amp;nbsp; immune diseases, US of liver&lt;br&gt;• Weekly LFTs. Give Vitamin K &lt;br&gt;&amp;nbsp; 10mg/24h if abn&amp;nbsp;clotting screen, &lt;br&gt;&amp;nbsp; and 1mg to baby at birth&lt;br&gt;• Typically induced at 37w&lt;br&gt;• Ursodeoxycholic acid ↓itch&lt;br&gt;• Smx resolve w/in 1w of delivery&lt;br&gt;• Can recur with COCP and ≤70% &lt;br&gt;&amp;nbsp; subsequent pregnancies" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00bbf9;" parent="1" vertex="1">
          <mxGeometry x="260" y="1213.5" width="190" height="176.5" as="geometry" />
        </mxCell>
        <mxCell id="V4_7HxQHBq3fb8EW7zNI-2" value="Acute fatty liver of pregnancy&lt;br&gt;• Rare but serious&lt;br&gt;• Abn pain, jaundice, HA, vomitting ±&lt;br&gt;&amp;nbsp; thrombocytopaenia, pancreatitis&lt;br&gt;• a/w pre-eclampsia in 30-60%&lt;br&gt;• Complications: coma, death&lt;br&gt;• Mx in HDU/ITU – supportive tx. &lt;br&gt;&amp;nbsp; Expedite delivery&lt;br&gt;&amp;nbsp; ↳❗️epidural, regional anaesthesia &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; contraindicated" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00bbf9;" parent="1" vertex="1">
          <mxGeometry x="260" y="1400" width="190" height="140" as="geometry" />
        </mxCell>
        <mxCell id="V4_7HxQHBq3fb8EW7zNI-3" value="Other causes of jaundice:&lt;br&gt;• BBV&amp;nbsp;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;• Severe pre-eclampsia&lt;br&gt;• HELLP syndrome&lt;br&gt;• Anaesthesia (halothane)" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00bbf9;" parent="1" vertex="1">
          <mxGeometry x="260" y="1550" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="E0Kh3P3iGb_ejasarKZ3-1" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;• Advice against travelling to&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; endemic areas, or to use&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; preventative measures (eg&lt;br style=&quot;border-color: var(--border-color);&quot;&gt;&amp;nbsp; mosquito nets, insect repellants)&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00f5d4;" parent="1" vertex="1">
          <mxGeometry x="480" y="1010" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-1" value="Renal disease in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#540d6e;fontColor=#FFFFFF;strokeColor=#540D6E;" vertex="1" parent="1">
          <mxGeometry x="480" y="1100" width="170" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-2" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Asymptomatic bacteriuria&lt;br&gt;• 2% of sexually active women&lt;br&gt;• ≤7% pregnant women, ↑in DM, &lt;br&gt;&amp;nbsp; renal transplants. 30% develop into &lt;br&gt;&amp;nbsp; pyelonephritis&lt;br&gt;• If present on MSU, abx given&lt;br&gt;&amp;nbsp; ☝🏻cefalexin 500 mg tds PO for 5d&lt;br&gt;&amp;nbsp; ✌🏻trimethoprim (avoid in 1st)&lt;br&gt;&amp;nbsp; ✌🏻nitrofurantoin (avoid in 3rd)&lt;br&gt;&amp;nbsp;&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#540D6E;" vertex="1" parent="1">
          <mxGeometry x="480" y="1130" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-3" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Pyelonephritis&lt;br&gt;• 1-2% of pregnant women&lt;br&gt;• do blood and urine culture&lt;br&gt;• IV abx eg cefuroxime 1.5g/8h, &lt;br&gt;&amp;nbsp; consider stat dose gentamicin&lt;br&gt;• Continue IV abx for at least 24h, &lt;br&gt;&amp;nbsp; PO abx for 2-3w&lt;br&gt;• Repeat MSU to check eradication&lt;br&gt;• If ≥2 confirmed UTIs in pregnancy, &lt;br&gt;&amp;nbsp; do renal US, consider abx &lt;br&gt;&amp;nbsp; prophylaxis for rest of pregnancy&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#540D6E;" vertex="1" parent="1">
          <mxGeometry x="480" y="1265" width="190" height="155" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-4" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;AKI related to pregnancy&lt;br&gt;• 2/2 sepsis, haemolysis (eg HELLP &lt;br&gt;&amp;nbsp; syndrome), hypovolaemia, volume &lt;br&gt;&amp;nbsp; contraction (eg pre-eclampsia), &lt;br&gt;&amp;nbsp; drugs (esp NSAIDs)&amp;nbsp;&lt;br&gt;• Monitor UO and fluid balance &lt;br&gt;&amp;nbsp; (catheterisation needed). Aim for &lt;br&gt;&amp;nbsp; &amp;gt;30 mL/h output. + renal bloods&lt;br&gt;• Ref to specialist if needed&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#540D6E;" vertex="1" parent="1">
          <mxGeometry x="480" y="1430" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-8" value="Connective tissue disease in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ffd23f;fontColor=#000000;strokeColor=#ffd23f;" vertex="1" parent="1">
          <mxGeometry x="930" y="870" width="165" height="30" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-9" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Rheumatoid arthritis&lt;br&gt;• 75% improve during pregnancy, but &lt;br&gt;&amp;nbsp; 90% have flare in puerperium&lt;br&gt;• Medications&lt;br&gt;&amp;nbsp; - MTX not safe; stop ≥6mo before &lt;br&gt;&amp;nbsp; &amp;nbsp; conception&lt;br&gt;&amp;nbsp; - Leflunomide not safe&amp;nbsp;&lt;br&gt;&amp;nbsp; - Sulfasalazine, HCQ - safe&lt;br&gt;&amp;nbsp; - TNF α-blockers - ?safe&lt;br&gt;&amp;nbsp; - low dose corticosteroids may be &lt;br&gt;&amp;nbsp; &amp;nbsp; used to control smx&amp;nbsp;&lt;br&gt;&amp;nbsp; - paracetamol ☝🏻for pain relief&lt;br&gt;&amp;nbsp; - NSAIDs ok until 32w; risk of early &lt;br&gt;&amp;nbsp; &amp;nbsp; closure of ductus arteriosus&lt;br&gt;• Refer to obstetric anaesthetist due &lt;br&gt;&amp;nbsp; to risk of atlanto-axial subluxation&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" vertex="1" parent="1">
          <mxGeometry x="930" y="910" width="190" height="220" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-10" value="Epilepsy in pregnancy" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ee4266;fontColor=#FFFFFF;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="870" width="140" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-11" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;D: ~0.5% F of childbearing age&lt;br&gt;Other causes of seizures: eclampsia, cerebral vein thrombosis, intracranial mass, stroke, metabolic abn, drugs and withdrawal, etc&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="900" width="200" height="70" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-12" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#3bceac;fontColor=#000000;strokeColor=#3bceac;" vertex="1" parent="1">
          <mxGeometry x="40" y="1765" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-13" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#3bceac;" vertex="1" parent="1">
          <mxGeometry x="40" y="1795" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-14" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#9b5de5;fontColor=#FFFFFF;strokeColor=#9b5de5;" vertex="1" parent="1">
          <mxGeometry x="40" y="1925" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-15" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#9b5de5;" vertex="1" parent="1">
          <mxGeometry x="40" y="1955" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-16" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#0ead69;fontColor=#FFFFFF;strokeColor=#0ead69;" vertex="1" parent="1">
          <mxGeometry x="40" y="1845" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-17" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#0ead69;" vertex="1" parent="1">
          <mxGeometry x="40" y="1875" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-18" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#00bbf9;fontColor=#FFFFFF;strokeColor=#00bbf9;" vertex="1" parent="1">
          <mxGeometry x="40" y="2085" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-19" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00bbf9;" vertex="1" parent="1">
          <mxGeometry x="40" y="2115" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-20" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#f15bb5;fontColor=#FFFFFF;strokeColor=#f15bb5;" vertex="1" parent="1">
          <mxGeometry x="40" y="2005" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-21" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#f15bb5;" vertex="1" parent="1">
          <mxGeometry x="40" y="2035" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-22" value="Pre-pregnancy counselling" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#00f5d4;fontColor=#000000;strokeColor=#00f5d4;" vertex="1" parent="1">
          <mxGeometry x="40" y="2165" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-23" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Immunisation: rubella&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#00f5d4;" vertex="1" parent="1">
          <mxGeometry x="40" y="2195" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-24" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Before pregnancy&lt;br&gt;• Optimise tx – aim for lowest dose&lt;br&gt;• &lt;b&gt;Folic acid 5mg for &amp;gt;3mo prior to &lt;br&gt;&amp;nbsp; conception&lt;/b&gt;&lt;br&gt;• Counsel about ↑risk of epilepsy in &lt;br&gt;&amp;nbsp; children (4-5% if either parent, 15-&lt;br&gt;&amp;nbsp; 20% if both parents)&lt;br&gt;• Specific points on drugs&lt;br&gt;&amp;nbsp; - Valproate a/w neural tube defects&lt;br&gt;&amp;nbsp; - Carbamazepine: considered the &lt;br&gt;&amp;nbsp; &amp;nbsp; least teratogenic of older AEDs&lt;br&gt;&amp;nbsp; - Phenytoin a/w cleft palate&lt;br&gt;&amp;nbsp; - Lamotrigine: possibly lower rates&amp;nbsp;of &lt;br&gt;&amp;nbsp; &amp;nbsp; congenital malformations than other &lt;br&gt;&amp;nbsp; &amp;nbsp; AEDs. May need to ↑dose&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="980" width="200" height="205" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-25" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;During pregnancy&lt;br&gt;• Consultant-led clinic with aim for &lt;br&gt;&amp;nbsp; vaginal delivery&lt;br&gt;• &lt;span style=&quot;background-color: rgb(255, 219, 219);&quot;&gt;NT and anomaly scans (±fetal echo) &lt;br&gt;&amp;nbsp; and then serial growth scans in 3rd &lt;br&gt;&amp;nbsp; trim (↑risk of SGA fetus)&lt;/span&gt;&lt;br&gt;• 5mg folic acid daily for 1st trim&lt;br&gt;• Routine drug level testing not rec&lt;br&gt;• &lt;span style=&quot;background-color: rgb(255, 219, 219);&quot;&gt;Stress and sleep deprivation ↑risk of &lt;br&gt;&amp;nbsp; seizures&lt;/span&gt; – AVOID&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="1195" width="200" height="140" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-26" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Intrapartum&lt;br&gt;• Delivery in hospital, continue AEDs&lt;br&gt;• Pain relief: epidural safe&lt;br&gt;• Benzos if seizure not self-terminating &lt;br&gt;&amp;nbsp; (eg lorazepam 4 mg IV)&lt;br&gt;• Seizures more common intrapar-&lt;br&gt;&amp;nbsp; tum and postpartum ∵ ↓sleep&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="1345" width="200" height="100" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-27" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Postpartum&lt;br&gt;• Vitamin K 1mg to baby&lt;br&gt;• Inpt for 24h postpartum – ↑risk&lt;br&gt;• Advise on strategies to avoid drop-&lt;br&gt;&amp;nbsp; ping baby if seizure occurs, eg &lt;br&gt;&amp;nbsp; changing baby on floor&lt;br&gt;• Encourage bfding and review AED &lt;br&gt;&amp;nbsp; dose w/in 10d of delivery to avoid tox&lt;br&gt;• Discuss contraception&lt;br&gt;&amp;nbsp; ↳ CI estrogen-containing drugs; &lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;↑risk of seizures with&amp;nbsp;lamotrigine&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ee4266;" vertex="1" parent="1">
          <mxGeometry x="700" y="1455" width="200" height="150" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-28" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;SLE&lt;br&gt;• Flares commoner in pregnancy and &lt;br&gt;&amp;nbsp; periperium – can ↑risk to baby&lt;br&gt;• Planned pregnancies during &lt;br&gt;&amp;nbsp; remission have better outcomes &lt;br&gt;&amp;nbsp; (similar to general population)&lt;br&gt;• Disease flares should be Mxed with &lt;br&gt;&amp;nbsp; corticosteroids + HCQ&amp;nbsp;&lt;br&gt;• Aspirin 75-150 mg from +ve &lt;br&gt;&amp;nbsp; pregnancy test till delivery&lt;br&gt;• If mother is Ro+ve, 2% risk of &lt;br&gt;&amp;nbsp; congenital heart block and 5% &lt;br&gt;&amp;nbsp; transient neonatal cutaneous lupus&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" vertex="1" parent="1">
          <mxGeometry x="930" y="1140" width="190" height="175" as="geometry" />
        </mxCell>
        <mxCell id="KNJIhbM8AVk_6OE6TxUk-29" value="&lt;font style=&quot;font-size: 11px;&quot;&gt;Antiphospholipid syndrome&lt;br&gt;• If untreated, &amp;lt;20% pregnancies &lt;br&gt;&amp;nbsp; proceed to live birth due to 1st trim &lt;br&gt;&amp;nbsp; loss or placental thrombosis&lt;br&gt;• ↑risk of pre-eclampsia and IUGR&lt;br&gt;• Mx&lt;br&gt;&amp;nbsp; - Uterine artery Dopplers at 20-24w&lt;br&gt;&amp;nbsp; - If high risk, 4wkly fetal growth &lt;br&gt;&amp;nbsp; &amp;nbsp; scans including umbilical artery &lt;br&gt;&amp;nbsp; &amp;nbsp; Dopplers from 28w&lt;br&gt;&amp;nbsp; - Aspirin 75-150mg OD if no &lt;br&gt;&amp;nbsp; &amp;nbsp; previous adverse outcomes (live &lt;br&gt;&amp;nbsp; &amp;nbsp; birth rate 70-80%)&lt;br&gt;&amp;nbsp; - If previous fetal loss + LMWH &lt;br&gt;&amp;nbsp; &amp;nbsp; (enoxaparin 40 mg SC) when fetal &lt;br&gt;&amp;nbsp; &amp;nbsp; heart identified (~6w) throughout &lt;br&gt;&amp;nbsp; &amp;nbsp; pregnancy&lt;br&gt;&amp;nbsp; - Postpartum: heparin or warfarin&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/font&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;fontSize=11;strokeColor=#ffd23f;" vertex="1" parent="1">
          <mxGeometry x="930" y="1325" width="190" height="245" as="geometry" />
        </mxCell>
      </root>
    </mxGraphModel>
  </diagram>
  <diagram name="Contraception" id="dxfj8acEbrbC3p2BVHpl">
    <mxGraphModel dx="620" dy="674" grid="1" gridSize="5" guides="1" tooltips="1" connect="1" arrows="1" fold="1" page="1" pageScale="1" pageWidth="1169" pageHeight="827" math="0" shadow="0">
      <root>
        <mxCell id="0" />
        <mxCell id="1" parent="0" />
        <mxCell id="DeUb8Rk8PS-adc19VPpk-15" value="Contraception" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;" parent="1" vertex="1">
          <mxGeometry x="40" y="40" width="90" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-30" value="COCP" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fec5bb;strokeColor=#997771;" parent="1" vertex="1">
          <mxGeometry x="40" y="80" width="45" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-31" value="MOA: Thickens cervical mucus" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="70" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-33" value="MOA:&amp;nbsp;Inhibits ovulation" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="110" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-34" value="Progesterone-only pill" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#FCD5CE;strokeColor=#917B77;" parent="1" vertex="1">
          <mxGeometry x="260" y="40" width="135" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-35" value="How to take&lt;br style=&quot;font-size: 11px;&quot;&gt;• If started within 5d of cycle, no&amp;nbsp; &lt;br&gt;&amp;nbsp; need for additional C&lt;br style=&quot;font-size: 11px;&quot;&gt;• If started &amp;gt;5d after, need&lt;br style=&quot;font-size: 11px;&quot;&gt;• Take same time every day&lt;br style=&quot;font-size: 11px;&quot;&gt;• Tailored regimes (pt pref)&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - no pill-free interval&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - 21d take, 4-7d break&lt;br style=&quot;font-size: 11px;&quot;&gt;• Intercourse during pill-free&amp;nbsp;period &lt;br&gt;&amp;nbsp; safe only if next pack started on &lt;br&gt;&amp;nbsp; time" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="140" width="190" height="150" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-37" value="SE&lt;br style=&quot;font-size: 11px;&quot;&gt;• ↑VTE, heart attacks, strokes&lt;br style=&quot;font-size: 11px;&quot;&gt;• ↑risk of &lt;span style=&quot;background-color: rgb(252, 213, 206); font-size: 11px;&quot;&gt;breast and cervical Ca&lt;/span&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="465" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-38" value="Benefits&lt;br style=&quot;font-size: 11px;&quot;&gt;• ↓risk of ovarian, endometrial, &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; colorectal Ca&lt;br style=&quot;font-size: 11px;&quot;&gt;• ? better periods" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="520" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-39" value="UK Medical Eligibility Criteria (UKMEC) – &lt;span style=&quot;background-color: rgb(252, 213, 206); font-size: 11px;&quot;&gt;Class 4 [&lt;b style=&quot;font-size: 11px;&quot;&gt;&lt;u style=&quot;font-size: 11px;&quot;&gt;CI&lt;/u&gt;&lt;/b&gt;]&lt;/span&gt;:&lt;br style=&quot;font-size: 11px;&quot;&gt;• &amp;gt;35yo + smoking &amp;gt;15/d&lt;br style=&quot;font-size: 11px;&quot;&gt;• migraine with aura&lt;br style=&quot;border-color: var(--border-color); font-size: 11px;&quot;&gt;• Hx of VTE, stroke, TIA&lt;br style=&quot;border-color: var(--border-color); font-size: 11px;&quot;&gt;• uncontrolled HTN&lt;br style=&quot;font-size: 11px;&quot;&gt;• current breast Ca&lt;br style=&quot;font-size: 11px;&quot;&gt;• major surgery + immobilisation&lt;br style=&quot;font-size: 11px;&quot;&gt;• +ve antiphospholipids abs (eg in &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; SLE)&lt;br&gt;Also CI in first 21d post-partum due &lt;br&gt;&amp;nbsp; to ↑risk of VTE" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="590" width="190" height="165" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-40" value="• 1 missed pill: take last pill even if it &lt;br&gt;&amp;nbsp; means taking 2 pills in one day. &lt;br&gt;&amp;nbsp; then cont taking pills OD.&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;• ≥2 missed:&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - as above + barrier for 7d&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - if ≥2 missed in week 1: consider&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; &amp;nbsp; emergency contraception if &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; &amp;nbsp; unprotected sex in pill-free interval &lt;br&gt;&amp;nbsp; &amp;nbsp; or in week 1&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - if ≥2 missed in week 2: ok&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - if ≥2 missed in week 3: finish all &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; &amp;nbsp; pills, skip pill-free interval" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="40" y="290" width="190" height="165" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-41" value="Injectable contraceptives" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#F8EDEB;strokeColor=#8A7C7A;" parent="1" vertex="1">
          <mxGeometry x="480" y="40" width="155" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-42" value="MOA:&amp;nbsp;Inhibits ovulation + ↑ cervical mucus, ↓ endometrium" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="70" width="190" height="35" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-43" value="Depo Provera =&amp;nbsp;medroxyprogesterone acetate 150mg&amp;nbsp; &amp;nbsp; &amp;nbsp;(most common in UK)&lt;br style=&quot;font-size: 11px;&quot;&gt;• IM injection q12w" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="115" width="190" height="60" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-44" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;SE&lt;span style=&quot;white-space: pre; font-size: 11px;&quot;&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;• irregular bleeding&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;• weight gain&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• ↑ risk of osteoporosis: avoid&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;use&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;in&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; adolescents if possible&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• not quickly reversible&amp;nbsp; and fertility&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; may return after a&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;varying time&lt;/span&gt;&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="175" width="190" height="85" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-45" value="UKMEC&amp;nbsp;&lt;span style=&quot;background-color: rgb(252, 213, 206); font-size: 11px;&quot;&gt;Class 4 [&lt;b style=&quot;font-size: 11px;&quot;&gt;&lt;u style=&quot;font-size: 11px;&quot;&gt;CI&lt;/u&gt;&lt;/b&gt;]&lt;/span&gt;:&lt;br style=&quot;font-size: 11px;&quot;&gt;• current breast Ca&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; [past breast Ca is class 3]" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="270" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-46" value="Implantable contraceptives" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#E8E8E4;strokeColor=#827C7B;" parent="1" vertex="1">
          <mxGeometry x="480" y="350" width="165" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-47" value="MOA:&amp;nbsp;Inhibits ovulation + &lt;br style=&quot;font-size: 11px;&quot;&gt;↑ cervical mucus" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#827C7B;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="380" width="190" height="30" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-48" value="Nexplanon / Implanon&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;= etonogestrel (progestogen)&lt;br style=&quot;font-size: 11px;&quot;&gt;• most effective form of C&lt;br style=&quot;font-size: 11px;&quot;&gt;• inserted subdermally overlying &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; the triceps&lt;br style=&quot;font-size: 11px;&quot;&gt;• applied q3y&lt;br style=&quot;font-size: 11px;&quot;&gt;• use other contraception for 7d if &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; not inserted on cycle day 1-5&lt;br&gt;• LARC of choice in young people" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#827C7B;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="420" width="190" height="125" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-49" value="SE&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;• irregular/heavy bleeding – may &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; need to be taken with COCP&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;• progestogen SE: HA, nausea, &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; mastalgia&lt;br style=&quot;font-size: 11px;&quot;&gt;• DDI with epileptic drugs" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#827C7B;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="555" width="190" height="85" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-50" value="UKMEC&amp;nbsp;&lt;span style=&quot;background-color: rgb(252, 213, 206); font-size: 11px;&quot;&gt;Class 4 [&lt;b style=&quot;font-size: 11px;&quot;&gt;&lt;u style=&quot;font-size: 11px;&quot;&gt;CI&lt;/u&gt;&lt;/b&gt;]&lt;/span&gt;:&lt;br style=&quot;font-size: 11px;&quot;&gt;• current breast Ca&lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; [past breast Ca is class 3]" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="480" y="650" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-51" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;How to take:&lt;/span&gt;&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• If started within 5d of cycle, or if&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; switching from COCP, no&amp;nbsp;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;need&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;for&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; additional C&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• If started &amp;gt;5d, need for 2d&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• Take same time every day&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• No pill-free interval; take OD&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="100" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-52" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;Missed pills&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• if &amp;lt; 3h late: continue as normal&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• if &amp;gt;3h: take the missed pill&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; asap&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;,&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;continue with the rest of&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;the&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; pack + extra precautions&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;for&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;48h&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;* For&amp;nbsp;Cerazette (desogestrel) a 12h&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; period is allowed&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#917B77;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="200" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-53" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;SE&lt;span style=&quot;white-space: pre; font-size: 11px;&quot;&gt; &lt;/span&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;• irregular bleeding&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• diarrhoea and vomiting –&amp;nbsp; might&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; need&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;to take again if pill is&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;vomited&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; up (follow missed day&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;rules)&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• Abx &lt;i style=&quot;font-size: 11px;&quot;&gt;no&lt;/i&gt; effect on POP, except for&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; induce CYP450&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;• Liver enzyme inducers :|&lt;/span&gt;&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="330" width="190" height="100" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-54" value="Intrauterine systems (IUS)" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#D8E2DC;strokeColor=#80807D;" parent="1" vertex="1">
          <mxGeometry x="700" y="40" width="160" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-55" value="MOA: ↑cervical mucus,&lt;br&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;&amp;nbsp; ↓endometrium" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="70" width="190" height="30" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-56" value="Mirena: 5y. 24 mcg/d = 52 mg&amp;nbsp;&lt;br style=&quot;font-size: 11px;&quot;&gt;Kyleena: 5y. 19.5 mg&lt;br style=&quot;font-size: 11px;&quot;&gt;Jaydess: 3y. 13.5 mg&lt;br style=&quot;font-size: 11px;&quot;&gt;• effective in 7d&lt;br style=&quot;font-size: 11px;&quot;&gt;• if Mirena used as HRT, licensed &lt;br style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; for only 4y" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="110" width="190" height="85" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-57" value="SE for IUS/IUD&lt;br style=&quot;font-size: 11px;&quot;&gt;• IUD: heavier, longer, more&amp;nbsp;painful &lt;br&gt;&amp;nbsp; periods&lt;br style=&quot;font-size: 11px;&quot;&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• IUS a/w initial frequent uterine&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; bleeding and spotting;&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;later&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;women&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; typically have&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;intermittent light menses with&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;less dysmenorrhoea; some&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;become amenorrhoeic&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• uterine perforation: up to&amp;nbsp; 2 per&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; 1000 &lt;span style=&quot;background-color: initial;&quot;&gt;insertions and higher in&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; breastfeeding women&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• ectopic pregnancies:&amp;nbsp;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;proportion&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;↑,&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; but absolute number ↓&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;compared&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; to&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;no contraception&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• small ↑risk of PID in first 20d,&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;then&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; risk returns to standard&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;•&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial; font-size: 11px;&quot;&gt;expulsion: risk is around 1 in 20,&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; most likely to occur in the&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;first 3mo&lt;/span&gt;&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="365" width="190" height="245" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-58" value="Copper device (IUD)" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ECE4DB;strokeColor=#80807D;" parent="1" vertex="1">
          <mxGeometry x="700" y="220" width="125" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-59" value="MOA: ↓sperm motility + survival" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="250" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-60" value="• effective immediately&lt;br style=&quot;font-size: 11px;&quot;&gt;• 5y efficacy if copper on stem&amp;nbsp;only; &lt;br&gt;&amp;nbsp; 10y if stem and arms with copper" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="280" width="190" height="45" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-62" value="Use seems generally restricted to pts who cannot take COCP" style="text;html=1;strokeColor=none;fillColor=none;align=left;verticalAlign=top;whiteSpace=wrap;rounded=0;fontSize=9;fontColor=#000000;spacing=0;spacingTop=-5;fontStyle=2" parent="1" vertex="1">
          <mxGeometry x="265" y="435" width="180" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-64" value="Emergency contraception" style="swimlane;whiteSpace=wrap;html=1;labelBackgroundColor=none;strokeColor=#8A7B75;fillColor=#FAE0D5;startSize=25;" parent="1" vertex="1">
          <mxGeometry x="920" y="40" width="200" height="530" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-63" value="Hormonal pills" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#FAE0D5;strokeColor=#807B76;" parent="DeUb8Rk8PS-adc19VPpk-64" vertex="1">
          <mxGeometry x="5" y="30" width="95" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-65" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;font style=&quot;font-size: 11px;&quot;&gt;&lt;b&gt;Levonorgestrel&lt;/b&gt; (emergency pill)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;font style=&quot;font-size: 11px;&quot;&gt;• MOA not fully understood – acts&amp;nbsp;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; both to stop ovulation, inhibit&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; implantation&lt;/span&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;• take asap, must be within 72h of&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; UPSI; efficacy ↓ as time passes&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; ↳ 84% effective if within 72h&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;• double dose for BMI &amp;gt;26 or &amp;gt;70kg&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• SE: - disturbance of menses&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; - vomiting – if within 3h of taking&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; &amp;nbsp; pill, repeat dose&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;labelBackgroundColor=none;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="DeUb8Rk8PS-adc19VPpk-64" vertex="1">
          <mxGeometry x="5" y="55" width="190" height="150" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-66" value="&lt;b&gt;Ulipristal&lt;/b&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp;(morning after; EllaOne)&lt;/span&gt;&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;div&gt;• MOA:&amp;nbsp;&lt;span style=&quot;background-color: initial;&quot;&gt;selective progesterone&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; receptor modulator; ❌ ovulation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;• 30mg oral dose taken asap&lt;span style=&quot;background-color: initial;&quot;&gt;, no&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; later than 120h (5d) after UPSI&lt;/span&gt;&lt;/div&gt;&lt;div&gt;• do not use with emergency pill&lt;/div&gt;&lt;div&gt;• hormonal contraceptives – start 5d&amp;nbsp;&lt;/div&gt;&lt;div&gt;&amp;nbsp; after morning after pill&lt;/div&gt;&lt;div&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; ↳ use barrier protection&lt;/span&gt;&lt;/div&gt;&lt;div&gt;• do not breastfeed for 1w&lt;/div&gt;&lt;div&gt;• SE: caution with severe asthma&amp;nbsp;&lt;/div&gt;&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;labelBackgroundColor=none;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="DeUb8Rk8PS-adc19VPpk-64" vertex="1">
          <mxGeometry x="5" y="210" width="190" height="150" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-67" value="Copper IUD" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#FAE0D5;strokeColor=#807B76;" parent="DeUb8Rk8PS-adc19VPpk-64" vertex="1">
          <mxGeometry x="5" y="374" width="75" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-68" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;• ☝🏻– recommend to all ∵ efficacy&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; &amp;nbsp;↳ 99% effective regardless of&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;white-space: pre;&quot;&gt; &lt;/span&gt;menstrual cycle&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• must be inserted within 5d of UPSI&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; or up to 5d after likely ovulation&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&amp;nbsp; date&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;• can be left in for long-term.&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp;If pt&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; wishes to take it&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;out, leave in until&amp;nbsp;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size: 11px;&quot;&gt;&lt;span style=&quot;background-color: initial;&quot;&gt;&amp;nbsp; at least next period&lt;/span&gt;&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;labelBackgroundColor=none;strokeColor=#80807D;fillColor=#FFFFFF;fontSize=11;" parent="DeUb8Rk8PS-adc19VPpk-64" vertex="1">
          <mxGeometry x="5" y="399" width="190" height="126" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-70" value="Combined contraceptive patch (Evra)" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fae1dd;strokeColor=#8A7C7A;" parent="1" vertex="1">
          <mxGeometry x="260" y="480" width="150" height="35" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-71" value="MOA:&amp;nbsp;Inhibits ovulation" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="525" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-72" value="• Apply 1 patch/wk for 3wks, then &lt;br&gt;&amp;nbsp; 1w patch-free (withdrawal bleed)&lt;br&gt;• If patch change delayed &amp;gt;48h:&lt;br&gt;&amp;nbsp; - put on new one asap&lt;br&gt;&amp;nbsp; - use barrier contraception for 7d&lt;br&gt;&amp;nbsp; ± emergency contraception&lt;br&gt;• If new cycle started late, use barrier &lt;br&gt;&amp;nbsp; contraception for 7d" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="555" width="190" height="110" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-74" value="&lt;u&gt;Contraception in women ≥50yo&lt;/u&gt;:&lt;br style=&quot;font-size: 10px;&quot;&gt;• Non-hormonal: stop after 1y amenorrhea&lt;br style=&quot;font-size: 10px;&quot;&gt;• COCP: switch to non-hormonal or &lt;br&gt;&amp;nbsp; progesterone-only&lt;br style=&quot;font-size: 10px;&quot;&gt;• Depo-Provera: switch to non-hormonal + &lt;br&gt;&amp;nbsp; stop after 2y of amenorrhea, or switch to &lt;br&gt;&amp;nbsp; progesterone-only&lt;br style=&quot;font-size: 10px;&quot;&gt;• Implant, POP, IUS: continue&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - if amenorrhic, check FSH, and stop after &lt;br&gt;&amp;nbsp; &amp;nbsp; 1y if FSH ≥30 ul/, or stop at 55y&lt;br style=&quot;font-size: 10px;&quot;&gt;&amp;nbsp; - otherwise, consider Ix of abn bleeding &lt;br&gt;&amp;nbsp; &amp;nbsp; pattern" style="shape=note;whiteSpace=wrap;html=1;backgroundOutline=1;darkOpacity=0.05;labelBackgroundColor=none;strokeColor=#d6b656;fontSize=10;fillColor=#fff2cc;size=13;align=left;verticalAlign=top;spacingTop=-7;spacing=5;" parent="1" vertex="1">
          <mxGeometry x="920" y="580" width="210" height="150" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-75" value="Pts who have gastric sleeve, bypass, etc&lt;br&gt;should never have oral contraception (incl emergency) because of ↓efficacy.&amp;nbsp;" style="shape=note;whiteSpace=wrap;html=1;backgroundOutline=1;darkOpacity=0.05;labelBackgroundColor=none;strokeColor=#d6b656;fontSize=10;fillColor=#fff2cc;size=13;align=left;verticalAlign=top;spacingTop=-7;spacing=5;" parent="1" vertex="1">
          <mxGeometry x="920" y="740" width="210" height="40" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-76" value="? ↓ efficacy in wt &amp;gt;90kg" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="665" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-77" value="&lt;u&gt;Contraception in transgendered pts&lt;/u&gt;:&lt;br style=&quot;font-size: 10px;&quot;&gt;Assigned F at birth, with uterus:&lt;br&gt;• Testosterone will not protect against preg&lt;br&gt;• If pt gets pregnant, &lt;b&gt;testosterone is CI&lt;/b&gt;&lt;br&gt;• Don&#39;t mix estrogen with testosterone&lt;br&gt;• Best option is likely POP&lt;br&gt;Assigned M at birth&lt;br&gt;• Condoms are still the safest&lt;br&gt;• ↓ sperm production with most of the &lt;br&gt;&amp;nbsp; contraceptive options, but none reliable" style="shape=note;whiteSpace=wrap;html=1;backgroundOutline=1;darkOpacity=0.05;labelBackgroundColor=none;strokeColor=#d6b656;fontSize=10;fillColor=#fff2cc;size=13;align=left;verticalAlign=top;spacingTop=-7;spacing=5;" parent="1" vertex="1">
          <mxGeometry x="695" y="655" width="210" height="125" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-78" value="&lt;u&gt;Pts with epilepsy&lt;/u&gt;: avoid COCP and POP,&amp;nbsp;&lt;br&gt;best options are Depo-Provera, IUD, IUS and physical barriers. If using COCP,&amp;nbsp;minimum of 30 µg ethinylestradiol required.&amp;nbsp;" style="shape=note;whiteSpace=wrap;html=1;backgroundOutline=1;darkOpacity=0.05;labelBackgroundColor=none;strokeColor=#d6b656;fontSize=10;fillColor=#fff2cc;size=13;align=left;verticalAlign=top;spacingTop=-7;spacing=5;" parent="1" vertex="1">
          <mxGeometry x="470" y="725" width="210" height="55" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-79" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;👍🏻 can use any time post-partum!&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="260" y="310" width="190" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-80" value="&lt;div style=&quot;font-size: 11px;&quot;&gt;👍🏻 IUS/IUDs can be inserted 48h after childbirth, or after 4w&lt;/div&gt;" style="rounded=0;whiteSpace=wrap;html=1;spacingTop=-7;spacing=5;align=left;verticalAlign=top;strokeColor=#8A7C7A;fillColor=#FFFFFF;fontSize=11;" parent="1" vertex="1">
          <mxGeometry x="700" y="335" width="190" height="30" as="geometry" />
        </mxCell>
        <mxCell id="juP-GqqcQ-gWfKqc5lZK-1" value="" style="group" parent="1" vertex="1" connectable="0">
          <mxGeometry x="1185" y="485" width="35" height="200" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-3" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fec5bb;strokeColor=#997771;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-4" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fcd5ce;strokeColor=#917B77;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="20" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-5" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fae1dd;strokeColor=#8A7C7A;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="40" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-6" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#f8edeb;strokeColor=#827C7B;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="60" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-7" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#e8e8e4;strokeColor=#80807D;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="80" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-8" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#D8E2DC;strokeColor=#7A807C;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="100" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-9" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ECE4DB;strokeColor=#807B76;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="120" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-10" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#FAE0D5;strokeColor=#8A7C75;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="140" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-11" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#ffd7ba;strokeColor=#917B6A;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="160" width="35" height="20" as="geometry" />
        </mxCell>
        <mxCell id="DeUb8Rk8PS-adc19VPpk-12" value="x" style="rounded=1;whiteSpace=wrap;html=1;spacingTop=0;fontStyle=1;align=left;spacing=5;fillColor=#fec89a;strokeColor=#9C7A5E;" parent="juP-GqqcQ-gWfKqc5lZK-1" vertex="1">
          <mxGeometry y="180" width="35" height="20" as="geometry" />
        </mxCell>
      </root>
    </mxGraphModel>
  </diagram>
</mxfile>
